Our medical director honoured with new epilepsy post
We are thrilled to announce that our medical director, Professor Ley Sander, has been appointed as Head of the Department of Clinical and Experimental Epilepsy at UCL Queen Square Institute of Neurology.
He will take up the position on 1 December 2018 leading the highly successful comprehensive epilepsy department, ranked number one in the world and spanning basic science through to clinical trials.
He will be providing leadership to the department alongside his continuing work with Epilepsy Society.
Brightest minds in epilepsy
Ley said: ‘This is a wonderful opportunity to really push forward our epilepsy research programmes and bring exciting developments to the people we see in clinics. I am thrilled to be heading up the department of clinical and experimental epilepsy which boasts some of the brightest minds offering the greatest hope for people with epilepsy.
‘Epilepsy is not just one condition, it is many conditions. It is also closely associated with other major diseases such as cancer, stroke and cardiovascular disease.
‘I would like to see us take a far more holistic approach to the diagnosis and treatment of epilepsy and look forward to realising this goal with this world renowned team. ‘
Professor Michael Hanna, Director of UCL Queen Square Institute of Neurology, said: “ I am delighted that Ley Sander has been appointed as head at this very important time with major opportunities for our world leading epilepsy research programmes, including the expansion of the Institute to include our new £240m translational neuroscience building due to complete in 2022/23. Ley brings strong leadership experience along-side a highly successful clinical epilepsy research programme with major international reach”
Ley was appointed Consultant Neurologist in 1994 and Professor at the UCL Institute of Neurology in 1999. Since 2012 he has been Medical Director of Epilepsy Society's Chalfont Centre for Epilepsy. He is the Research and Develepment Director of Stichting Epilepsie Instellingen Nederland (SEIN) in Heemstede, The Netherlands and a visiting professor of neurology at Sichuan University, China.
Ley's research interests
His main research interests are in the epidemiology, outcomes and genetics of epilepsy; the medical and surgical management of chronic epilepsy; and the delivery of epilepsy care in resource-poor settings.
He is currently overseeing eight PhD students having previously supervised to completion 24 higher degrees. He has more than 750 publications to his name, including original research articles, reviews, books and book chapters. He is a member of the editorial board of the Lancet Neurology and a neurological advisor to the British National Formulary.
He has obtained many postgraduate awards prizes including the Research Recognition Award for Clinical Sciences of the American Epilepsy Society, the Innovation and Sustainability in Health Award, the BUPA Foundation Epidemiology Award, the European Gower's Prize, the Baldev Singh Award and the Ambassador for Epilepsy Award.
Share this article: